KUALA LUMPUR, Feb 21 — Mah Sing Group Bhd’s healthcare business unit, Mah Sing Healthcare Sdn Bhd, has obtained the 510 Premarket Notification clearances to market medical-grade examination gloves for use with chemotherapy drugs in the United States market.
“The chemotherapy protection is often a critical consideration when evaluating exam grade gloves. Chemo gloves are products that have been tested and approved to protect against chemotherapy drugs. Mah Sing said its nitrile examination gloves have been tested for use with chemotherapy drugs from the US Food and Drug Administration and will be updated on the FDA website in due course.